PMC · DOI:10.3389/fphar.2024.1396034·April 18, 2024
Editorial: Novel methods and technologies for the evaluation of drug outcomes and policies
Blythe Adamson, Amr Makady, Grammati Sarri, Omneya Mohamed, Zaheer Babar, Dalia M. Dawoud
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Species1
Chemicals2
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsComputational Drug Discovery Methods · Health Systems, Economic Evaluations, Quality of Life